During the past decade, CHU Brabois conducted 222 clinical trials. In the 10-year time frame, 222 clinical trials started and 41 clinical trials were completed, i.e. on average, 18.5% percent of trials that started reached the finish line to date. In the past 5 years, 117 clinical trials started and 27 clinical trials were completed. i.e. 23.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHU Brabois" #1 sponsor was "Central Hospital, Nancy, France" with 46 trials, followed by "The Lymphoma Academic Research Organisation" with 25 trials sponsored, "Groupe Francophone des Myelodysplasies" with 22 trials sponsored, "Janssen Research & Development, LLC" with 12 trials sponsored and "Hoffmann-La Roche" with 12 trials sponsored. Other sponsors include 231 different institutions and companies that sponsored additional 126 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU Brabois" #1 collaborator was "Novartis" with 8 trials as a collaborator, "Celgene Corporation" with 6 trials as a collaborator, "AbbVie" with 5 trials as a collaborator, "Hoffmann-La Roche" with 4 trials as a collaborator and "Janssen-Cilag Ltd." with 4 trials as a collaborator. Other collaborators include 161 different institutions and companies that were collaborators in the rest 138 trials.

According to Clinical.Site data, the most researched conditions in "CHU Brabois" are "Myelodysplastic Syndromes" (15 trials), "Ulcerative Colitis" (13 trials), "Crohn's Disease" (11 trials), "Multiple Myeloma" (11 trials) and "Acute Myeloid Leukemia" (10 trials). Many other conditions were trialed in "CHU Brabois" in a lesser frequency.

Most popular intervention types in "CHU Brabois" are "Drug" (229 trials), "Other" (51 trials), "Procedure" (36 trials), "Device" (28 trials) and "Biological" (27 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (44 trials), "Lenalidomide" (14 trials), "Rituximab" (14 trials), "Dexamethasone" (11 trials) and "Cyclophosphamide" (10 trials). Other intervention names were less common.

The vast majority of trials in "CHU Brabois" are 345 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are 130 active trials in "CHU Brabois". 10 are not yet recruiting, 78 are recruiting, 41 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 166 completed trials in CHU Brabois, undefined suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in CHU Brabois, 18 "Phase 1" clinical trials were conducted, 113 "Phase 2" clinical trials and 112 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 16 trials, and there were also 58 trials that are defined as “Not Applicable".